FDA
approval
· 2018-05-25
FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
Summary
FDA approved a supplemental application from Prasco Laboratories for a fixed-dose combination of amlodipine and atorvastatin (amlodipine besylate and atorvastat…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)